4.4 Article

Nationwide analysis of survival after radical cystectomy for bladder cancer in Finland

Journal

ACTA ONCOLOGICA
Volume 62, Issue 8, Pages 829-835

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/0284186X.2023.2228446

Keywords

Bladder cancer; radical cystectomy; overall survival; cancer-specific survival; muscle-invasive bladder cancer

Categories

Ask authors/readers for more resources

This study analyzed population-based data from Finland to report short and long-term survival outcomes of patients undergoing radical cystectomy for bladder cancer. The results showed that the volume of surgical centers was not significantly associated with surgical mortality or long-term survival. Survival rates and disease-specific survival rates varied significantly based on the pTNM staging, and the presence of lymph node metastases had a significant impact on patient survival.
BackgroundPopulation-based survival results after radical cystectomy (RC) are limited. Our objective was to report short and long-term survival results after RC for bladder cancer from Finland in a population-based setting.Materials and methodsThe Finnish National Cystectomy Database containing retrospectively collected essential RC data covering the years 2005-2017 was combined with the survival data from the Finnish Cancer Registry. Kaplan-Meier plots were used to estimate survival and the survival graphs were illustrated according to the final pathological staging. Centers were divided according to operational volume, and the results were then compared using Pearsons's Chi-squared test.ResultsA total of 2047 patients were included in the study. 30-, and 90-day mortality was 1.3%, and 3.8%, respectively. The OS of the entire RC population at 5- and 10 years was 66% and 55%, and CSS was 74% and 72%, respectively. Center volume did not significantly associate with surgical mortality or long-term survival. The 5- and 10-year OS according to pT-category was 87% and 74% for pT0, 85% and 69% for pTa-pTis-pT1, 70% and 58% for pT2, 50% and 42% for pT3 and 41% and 30% for pT4. The corresponding 5- and 10-year CSS rates were 96% and 93% for pT0, 91% and 90% for pTa-pTis-pT1, 78% and 75% for pT2, 56% and 55% for pT3 and 47% and 44% for pT4. The 5- and 10-year OS rates in patients with no lymph node metastases (pN-) were 74% and 62%, and CSS 82% and 80%, respectively. If lymph nodes were positive (pN+), the corresponding OS rates were 44% and 34% and CSS 49% and 48%, respectively.ConclusionRC survival results have improved in contemporary series and are associated with the pTNM-status. The nationwide results from Finland demonstrate outcome comparable to high volume single-center series.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available